Outlook Therapeutics Inc (OTLK)
8.60
+0.10
(+1.18%)
USD |
NASDAQ |
May 03, 16:00
8.57
-0.03
(-0.35%)
After-Hours: 20:00
Outlook Therapeutics Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2019 | -172.5% |
| June 30, 2019 | -760.6% |
| March 31, 2019 | -1.60K% |
| December 31, 2018 | -912.5% |
| September 30, 2018 | -1.58K% |
| June 30, 2018 | -1.09K% |
| March 31, 2018 | -976.8% |
| December 31, 2017 | -248.8% |
| September 30, 2017 | -219.6% |
| June 30, 2017 | -1.76K% |
| Date | Value |
|---|---|
| March 31, 2017 | -2.65K% |
| December 31, 2016 | -6.30K% |
| September 30, 2016 | -2.14K% |
| June 30, 2016 | -4.51K% |
| March 31, 2016 | -356.1% |
| December 31, 2015 | -1.70K% |
| September 30, 2015 | -3.47K% |
| June 30, 2015 | -875.8% |
| March 31, 2015 | -2.83K% |
| December 31, 2014 | -167.2% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-760.6%
Minimum
Jun 2019
-172.5%
Maximum
Sep 2019
-466.6%
Average
-466.6%
Median
Profit Margin (Quarterly) Benchmarks
| Cutera Inc | -91.30% |
| Actinium Pharmaceuticals Inc | -- |
| GT Biopharma Inc | -- |
| Karyopharm Therapeutics Inc | -124.0% |
| Marinus Pharmaceuticals Inc | -580.9% |